Daniel C. Andersson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Cardiomyocyte-intrinsic somatic mtDNA mutations induce an OXPHOS-dependent immune response and promote progressive heart failure.
Journal: Science advances
Published: September 04, 2026
MitoSAM-dependent lipoylation controls postnatal heart development via metabolic remodeling.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
The Orally Available Ghrelin Receptor-Agonist AC01 Improves Systolic Function in HFrEF Mice and Nonhuman Primates.
Journal: JACC. Basic to translational science
Published: March 31, 2026
Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum.
Journal: Annals of the rheumatic diseases
Published: November 18, 2025
Emerging therapeutic directions for inotropic therapy in heart failure.
Journal: Med (New York, N.Y.)
Published: November 13, 2025
Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.
Journal: Journal of autoimmunity
Published: October 23, 2025
Subspace-located catalase prevents membrane degradation and dyssynchronization of local calcium release in adult cardiomyocytes.
Journal: Free radical biology & medicine
Published: June 30, 2025
Post-prandial acyl ghrelin infusion in heart failure patients increases gastric emptying rate.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 04, 2025
Risk of ischaemic and non-ischaemic heart failure in patients with systemic sclerosis: a population-based study.
Journal: Rheumatology (Oxford, England)
Published: May 16, 2025
The ghrelin receptor agonist AC01 improves cardiomyocyte contractility through Gαi signalling and without Ca2+ mobilization.
Journal: Cardiovascular research
Published: March 14, 2025
Last Updated: 09/26/2026